Yu Min Kang
- Infectious Diseases top 2%
- Neurology top 5%
- Cardiology and Cardiovascular Medicine
- Oncology
- Molecular Biology
- Co-authors
- Jaegyun LimKang Won ChoeMoon Jung KimHyun‐Young ShinWang Jun LeeSeunghyun JeonSang-Joon ParkYuchi Han
- Topics
- COVID-19 Clinical Research Studies (11 papers)SARS-CoV-2 and COVID-19 Research (9 papers)Long-Term Effects of COVID-19 (4 papers)
- Partner nations
- South KoreaUnited StatesChina
In The Last Decade
Yu Min Kang
30 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Infectious Diseases 929
- Neurology 403
- Cardiology and Cardiovascular Medicine 138
- Oncology 127
- Molecular Biology 108
Countries citing papers authored by Yu Min Kang
This map shows the geographic impact of Yu Min Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Min Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Min Kang more than expected).
Fields of papers citing papers by Yu Min Kang
This network shows the impact of papers produced by Yu Min Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Min Kang. The network helps show where Yu Min Kang may publish in the future.
Co-authorship network of co-authors of Yu Min Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Yu Min Kang. A scholar is included among the top collaborators of Yu Min Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Min Kang. Yu Min Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 12 | |
| 7 | 13 | |
| 8 | 6 | |
| 9 | 28 | |
| 10 | 10 | |
| 11 | 229 | |
| 12 | 4 | |
| 13 | 26 | |
| 14 | 5 | |
| 15 | 282 | |
| 16 | 19 | |
| 17 | 23 | |
| 18 | 6 | |
| 19 | 16 | |
| 20 | 18 |
About Yu Min Kang
Yu Min Kang is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Long-Term Effects of COVID-19 (4 papers). The work is most often cited by research in Infectious Diseases (929 citations), Neurology (403 citations) and Modeling and Simulation (75 citations). Yu Min Kang has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Jaegyun Lim, Kang Won Choe, Moon Jung Kim, Hyun‐Young Shin, Wang Jun Lee, Seunghyun Jeon, Sang-Joon Park, Yuchi Han, Marielle Scherrer‐Crosbie and Victor A. Ferrari. Their work appears in journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.